Danaher Corporation $DHR Stake Lessened by 1248 Management LLC

Key Points

• 1248 Management LLC has reduced its holdings in Danaher Corporation by 25.0%, selling 2,050 shares and now owning 6,150 shares valued at approximately $1.26 million.
• Analysts have mixed views on Danaher; Barclays has an "overweight" rating with a target price raised to $225.00, while Wells Fargo downgraded its target to $205.00.
• Danaher reported better-than-expected earnings of $1.80 per share for the last quarter, exceeding estimates and showing a 3.4% increase in revenue year-over-year.

1248 Management LLC decreased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 25.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,150 shares of the conglomerate's stock after selling 2,050 shares during the period. Danaher accounts for 0.7% of 1248 Management LLC's investment portfolio, making the stock its 24th biggest position. 1248 Management LLC's holdings in Danaher were worth $1,263,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of DHR. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $27,000. Sierra Ocean LLC boosted its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the first quarter worth $31,000. Finally, Dunhill Financial LLC boosted its holdings in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.20% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Barclays restated an "overweight" rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Wells Fargo & Company reduced their target price on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. UBS Group reduced their target price on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Guggenheim restated a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Stock Down 0.2%

Shares of NYSE:DHR traded down $0.47 during trading on Thursday, hitting $198.97. The company's stock had a trading volume of 3,627,515 shares, compared to its average volume of 4,153,999. The stock's 50-day moving average price is $201.94 and its two-hundred day moving average price is $199.49. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The company has a market capitalization of $142.47 billion, a PE ratio of 42.33, a PEG ratio of 2.87 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.